PBE ETF — Invesco Dynamic Biotechnology & Genome ETF

Invesco Dynamic Biotechnology & Genome ETF (PBE)

Updated October 16, 2026.

PBE is an ETF. its distribution rate is 0.08%, its trailing-12-month yield is 1.39%, its expense ratio is 0.59%. Dividend Vision Distribution Safety Score™ is 97/100 (Safe). Total return is 589.0% over the past 21.3 years, 249.6 points behind SPY at 838.6%.

Invesco Dynamic Biotechnology & Genome ETF tracks an index of U.S. biotechnology and genome companies engaged in research, development, manufacturing, and distribution of biotechnological products and services, with at least 90% of assets invested in index securities. The fund carries a very modest distribution rate and pays distributions quarterly, with an expense ratio of 0.59%. It appeals primarily to investors seeking exposure to the biotechnology and genomics sector rather than those prioritizing dividend income.

PBE performance versus SPY

Price and return data through 2026-10-16.

Total return is 589.0% over the past 21.3 years, 249.6 points behind SPY at 838.6%. Over the past year its total return — price change plus distributions reinvested — is 36.1%. Its deepest 1-year drawdown was 11.7%.

PBE key facts

Distribution Safety Score™

97 · Safe

Safety-Adjusted Yield

0.08%

Issuer

Invesco

Asset type

ETF

Asset class

Equity

Inception date

06/23/2005

Expense ratio

0.59%

Distribution rate

0.08%

Distribution frequency

Quarterly

Trailing yield

1.39%

Last close

$96.08 (as of 2026-10-16)

AUM

$411,733,172

Average volume

11200.0

Dividend

$0.019

Ex-dividend date

09/21/2026

Payment date

09/25/2026

Beta

0.73

How Dividend Vision calculates yield and returns

Distribution rate (0.08%) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield (1.39%) is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: Invesco; prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

PBE risks and drawbacks

PBE's current distribution rate is moderate, not a high-yield payout — the strategy is dividend quality more than maximum income. Payments are quarterly, so cash flow is lumpy versus a monthly fund. Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 11.7%.

Who may consider PBE — and who may not

PBE may suit someone looking for a high Distribution Safety Score. It is a weaker fit for investors who need monthly cash flow (PBE pays quarterly); investors hunting double-digit covered-call yields; investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on PBE

• All tickers starting with P

Tagged: Healthcare.

Frequently asked questions

More securities from Invesco.